SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Emcure Pharma Reports Double-Digit Growth in September-Quarter Results

Emcure Pharma reported double-digit growth in revenue, EBITDA and net profit for the September quarter. Its shares gained as much as 7% in response to the results.

EMCURE

Emcure Pharma Ltd. reported results for the September quarter on Tuesday, November 3, which saw double-digit growth across its revenue, Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) and its Net Profit. The stock gained as much as 7% in response to the numbers.Revenue for the…

Related stories